Aisling Capital Management LP

Investment Portfolio & 13F Holdings Analysis

About

Type: FundHoldings: 13Value: $288.5MLatest: 2025Q1

Aisling Capital Management LP is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 13 holdings worth $0.3 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "BCAX",
  "NUVB",
  "SNDX",
  "GLUE",
  "CALC",
  "MRKR",
  "OKUR",
  "ACRS",
  "CMPS",
  "ELEV",
  "VRNA",
  "BMEA",
  "BBIO"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-13
Total Holdings: 13
Total Value: 288452197
Accession Number: 0001766721-25-000003
Form Type: 13F-HR
CIK: aisling-capital-management-lp
Manager Name: Aisling-Capital-Management-Lp

Data Enrichment

100% identified

13 identified0 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

13 positions • $288.5M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Sort by:

BridgeBio Pharma, Inc.

BBIO|10806X102

Shares:6.1M

Value:$209.8M

% of Portfolio:72.7% ($209.8M/$288.5M)

Verona Pharma plc

VRNA|925050106

Shares:615.4K

Value:$39.1M

% of Portfolio:13.5% ($39.1M/$288.5M)

Syndax Pharmaceuticals Inc

SNDX|87164F105

Shares:1.0M

Value:$12.6M

% of Portfolio:4.4% ($12.6M/$288.5M)

Bicara Therapeutics Inc.

BCAX|055477103

Shares:568.9K

Value:$7.4M

% of Portfolio:2.6% ($7.4M/$288.5M)

Monte Rosa Therapeutics, Inc.

GLUE|61225M102

Shares:1.5M

Value:$6.8M

% of Portfolio:2.4% ($6.8M/$288.5M)

Nuvation Bio Inc.

NUVB|67080N101

Shares:2.5M

Value:$4.5M

% of Portfolio:1.6% ($4.5M/$288.5M)

COMPASS Pathways plc

CMPS|20451W101

Shares:1.2M

Value:$3.4M

% of Portfolio:1.2% ($3.4M/$288.5M)

Biomea Fusion, Inc.

BMEA|09077A106

Shares:798.8K

Value:$1.7M

% of Portfolio:0.6% ($1.7M/$288.5M)

CalciMedica, Inc.

CALC|38942Q202

Shares:521.1K

Value:$995.3K

% of Portfolio:0.3% ($995.3K/$288.5M)

Elevation Oncology, Inc.

ELEV|28623U101

Shares:2.8M

Value:$734.5K

% of Portfolio:0.3% ($734.5K/$288.5M)

Aclaris Therapeutics, Inc.

ACRS|00461U105

Shares:434.5K

Value:$664.7K

% of Portfolio:0.2% ($664.7K/$288.5M)

Marker Therapeutics, Inc.

MRKR|57055L206

Shares:325.4K

Value:$400.2K

% of Portfolio:0.1% ($400.2K/$288.5M)

OnKure Therapeutics, Inc.

OKUR|68277Q105

Shares:88.6K

Value:$381.0K

% of Portfolio:0.1% ($381.0K/$288.5M)

Instrument	Shares		Other Manager	Value	% of Portfolio
BridgeBio Pharma, Inc.(BBIOcusip10806X102)	6.1M	QoQ 0.00% (+0) YoY 0.00% (+0)	All Managers (Combined)	$209.8M	72.7% ($209.8M/$288.5M)	QoQ +25.98% (+$43.3M) YoY +11.80% (+$22.1M)
Verona Pharma plc(VRNAcusip925050106)	615.4K	QoQ -44.82% (-500.0K) YoY -44.82% (-500.0K)	All Managers (Combined)	$39.1M	13.5% ($39.1M/$288.5M)	QoQ -24.57% (-$12.7M) YoY +117.70% (-$21.1M)
Syndax Pharmaceuticals Inc(SNDXcusip87164F105)	1.0M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$12.6M	4.4% ($12.6M/$288.5M)	QoQ -7.11% (-$963.5K) YoY -48.40% (-$11.8M)
Bicara Therapeutics Inc.(BCAXcusip055477103)	568.9K	QoQ 0.00% (-0) YoY NEW(+568.9K)	All Managers (Combined)	$7.4M	2.6% ($7.4M/$288.5M)	QoQ -25.20% (-$2.5M) YoY NEW(+$7.4M)
Monte Rosa Therapeutics, Inc.(GLUEcusip61225M102)	1.5M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$6.8M	2.4% ($6.8M/$288.5M)	QoQ -33.14% (-$3.4M) YoY -34.18% (-$3.5M)
Nuvation Bio Inc.(NUVBcusip67080N101)	2.5M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$4.5M	1.6% ($4.5M/$288.5M)	QoQ -33.83% (-$2.3M) YoY -51.64% (-$4.8M)
COMPASS Pathways plc(CMPScusip20451W101)	1.2M	QoQ +24.25% (-233.9K) YoY +24.25% (-233.9K)	All Managers (Combined)	$3.4M	1.2% ($3.4M/$288.5M)	QoQ -5.98% (-$218.3K) YoY -57.28% (-$4.6M)
Biomea Fusion, Inc.(BMEAcusip09077A106)	798.8K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$1.7M	0.6% ($1.7M/$288.5M)	QoQ -45.10% (-$1.4M) YoY -85.75% (-$10.2M)
CalciMedica, Inc.(CALCcusip38942Q202)	521.1K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$995.3K	0.3% ($995.3K/$288.5M)	QoQ -46.04% (-$849.4K) YoY -54.08% (-$1.2M)
Elevation Oncology, Inc.(ELEVcusip28623U101)	2.8M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$734.5K	0.3% ($734.5K/$288.5M)	QoQ -53.73% (-$853.0K) YoY -94.94% (-$13.8M)
Aclaris Therapeutics, Inc.(ACRScusip00461U105)	434.5K	QoQ 0.00% (-0) YoY 0.00% (+0)	All Managers (Combined)	$664.7K	0.2% ($664.7K/$288.5M)	QoQ -38.30% (-$412.7K) YoY +23.38% (+$126.0K)
Marker Therapeutics, Inc.(MRKRcusip57055L206)	325.4K	QoQ 0.00% (-0) YoY +3.52% (-11.1K)	All Managers (Combined)	$400.2K	0.1% ($400.2K/$288.5M)	QoQ -60.45% (-$611.7K) YoY -70.38% (-$951.2K)
OnKure Therapeutics, Inc.(OKURcusip68277Q105)	88.6K	QoQ 0.00% (-0) YoY NEW(+88.6K)	All Managers (Combined)	$381.0K	0.1% ($381.0K/$288.5M)	QoQ -50.00% (-$381.0K) YoY NEW(+$381.0K)